- Investing Ideas
- Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Bavarian Nordic
Market Cap: DKK 15.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 212.60
7D
13.2%
1Y
-10.6%
H. Lundbeck
Market Cap: DKK 40.6b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 41.16
7D
-4.6%
1Y
5.4%
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 302.45
7D
3.4%
1Y
-17.7%
H. Lundbeck
Market Cap: DKK 40.6b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN A
DKK 40.80
7D
12.1%
1Y
26.1%
Strategic Partners
Market Cap: DKK 29.2m
Does not have significant operations.
STRAP
DKK 700.00
7D
-6.0%
1Y
-32.7%